Rand M L, DaCosta S M, Chahil A, Kinlough-Rathbone R L
Department of Biochemistry, University of Toronto, Ontario, Canada.
Alcohol Clin Exp Res. 1995 Oct;19(5):1279-85. doi: 10.1111/j.1530-0277.1995.tb01612.x.
We have previously shown that acutely administered ethanol, resulting in blood alcohol concentrations of 40-90 mM, inhibits experimentally induced arterial thrombosis in rabbits. This inhibition by ethanol in vivo is more pronounced than that observed on stimulated platelets in vitro, when a similar concentration of ethanol is added before an aggregating agent. It may be, then, that ethanol has combined effects in vivo with other inhibitors of platelet function. Adenosine has been found to be an important mediator of some of the in vivo effects of ethanol, and we investigated whether ethanol has combined inhibitory effects with adenosine on thrombin-stimulated platelet responses in vitro. Aggregation and secretion of [14C]serotonin from washed, prelabeled rabbit platelets, pretreated with aspirin, were studied. Maximal aggregation induced by 0.15 units thrombin/ml was slightly inhibited by 87 mM ethanol; secretion of serotonin was reduced from 24% to 12%. However, when thrombin-induced aggregation was significantly reduced by 1 microM adenosine, ethanol, at 44 and 87 mM, further inhibited aggregation. Secretion of [14C]serotonin was reduced to < 3%, with the combination of adenosine and the higher concentration of ethanol. Ethanol did not increase platelet cyclic AMP (cAMP) above basal levels, nor did it affect the increase in cAMP caused by adenosine. The adenosine receptor antagonist, 8-phenyltheophylline, at 1 microM, blocked the inhibitory effects of adenosine on platelet responses and prevented the adenosine-induced increase in cAMP. Unexpectedly, however, 8-phenyltheophylline (1-2 microM) did not completely block the combined inhibitory effects of ethanol and adenosine; this incomplete reversal was not associated with increases in cAMP over basal levels.(ABSTRACT TRUNCATED AT 250 WORDS)
我们之前已经表明,急性给予乙醇,使血液酒精浓度达到40 - 90 mM,可抑制实验诱导的家兔动脉血栓形成。当在体外添加类似浓度的乙醇至聚集剂之前时,乙醇在体内的这种抑制作用比在受刺激血小板上观察到的更为明显。那么,乙醇在体内可能与其他血小板功能抑制剂具有联合作用。已发现腺苷是乙醇一些体内作用的重要介质,我们研究了乙醇与腺苷在体外对凝血酶刺激的血小板反应是否具有联合抑制作用。对用阿司匹林预处理过的、预先标记的家兔洗涤血小板中[14C]5 - 羟色胺的聚集和分泌进行了研究。0.15单位/毫升凝血酶诱导的最大聚集受到87 mM乙醇的轻微抑制;5 - 羟色胺的分泌从24%降至12%。然而,当1 microM腺苷显著降低凝血酶诱导的聚集时,44 mM和87 mM的乙醇进一步抑制聚集。腺苷与较高浓度乙醇联合使用时,[14C]5 - 羟色胺的分泌降至<3%。乙醇并未使血小板环磷酸腺苷(cAMP)升高至基础水平以上,也未影响腺苷引起的cAMP升高。1 microM的腺苷受体拮抗剂8 - 苯基茶碱可阻断腺苷对血小板反应的抑制作用,并阻止腺苷诱导的cAMP升高。然而,出乎意料的是,8 - 苯基茶碱(1 - 2 microM)并未完全阻断乙醇和腺苷的联合抑制作用;这种不完全逆转与cAMP超过基础水平的升高无关。(摘要截短于250字)